Tag: aviptadil

Biophore seeks DCGI emergency use approval of Aviptadil for Covid-19 – ET HealthWorld

New Delhi: Biophore India Pharmaceuticals on Friday announced that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19. Biophore has successfully developed Aviptadil, a synthetic form of Vasoactive Intestinal Peptide (VIP) for rapid Covid-19 clinical recovery and is backward […]

Read More